Assisted movement with enhanced sensation (AMES): Coupling motor and sensory to remediate motor deficits in chronic stroke patients

Paul Cordo, Helmi Lutsep, Linda Cordo, W. Geoffrey Wright, Timothy Cacciatore, Rachel Skoss

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

Background. Conventional methods of rehabilitation in patients with chronic, severe motor impairments after stroke usually do not lessen paresis. Objective. A novel therapeutic approach (assisted movement with enhanced sensation [AMES]) was employed in a medical device phase I clinical trial to reduce paresis and spasticity and, thereby, to improve motor function. Methods. Twenty subjects more than 1 year poststroke with severe motor disability of the upper or lower extremity were studied. A robotic device cycled the ankle or the wrist and fingers at 5°/s through ±17.5° in flexion and extension while the subject assisted this motion. Feedback of the subject's active torque was displayed on a monitor. Simultaneously, 2 vibrators applied a 60 pps stimulus to the tendons of the lengthening muscles, alternating from flexors to extensors as the joint rotation reversed from extension to flexion, respectively. Subjects treated themselves at home for 30 min/day for 6 months. Every other day prior to treatment, the therapy device performed automated tests of strength and joint positioning. Functional testing was performed prior to enrollment, immediately after completing the protocol, and 6 months later. Functional tests included gait and weight distribution (lower extremity subjects only) and the Stroke Impact Scale. Results. Most subjects improved on most tests, and gains were sustained for 6 months in most subjects. No safety problems arose. Conclusion. The AMES strategy appears safe and possibly effective in patients with severe chronic impairments. The mechanism underlying these gains is likely to be multifactorial.

Original languageEnglish (US)
Pages (from-to)67-77
Number of pages11
JournalNeurorehabilitation and Neural Repair
Volume23
Issue number1
DOIs
StatePublished - Jan 2009

Fingerprint

Stroke
Paresis
Equipment and Supplies
Lower Extremity
Joints
Tenotomy
Clinical Trials, Phase I
Torque
Robotics
Wrist
Gait
Ankle
Fingers
Therapeutics
Rehabilitation
Safety
Weights and Measures
Muscles

Keywords

  • Chronic
  • Movement
  • Rehabilitation
  • Stroke
  • Vibration

ASJC Scopus subject areas

  • Clinical Neurology
  • Rehabilitation
  • Neurology

Cite this

Assisted movement with enhanced sensation (AMES) : Coupling motor and sensory to remediate motor deficits in chronic stroke patients. / Cordo, Paul; Lutsep, Helmi; Cordo, Linda; Wright, W. Geoffrey; Cacciatore, Timothy; Skoss, Rachel.

In: Neurorehabilitation and Neural Repair, Vol. 23, No. 1, 01.2009, p. 67-77.

Research output: Contribution to journalArticle

Cordo, Paul ; Lutsep, Helmi ; Cordo, Linda ; Wright, W. Geoffrey ; Cacciatore, Timothy ; Skoss, Rachel. / Assisted movement with enhanced sensation (AMES) : Coupling motor and sensory to remediate motor deficits in chronic stroke patients. In: Neurorehabilitation and Neural Repair. 2009 ; Vol. 23, No. 1. pp. 67-77.
@article{9aedbd3314624625b06324b6da516d82,
title = "Assisted movement with enhanced sensation (AMES): Coupling motor and sensory to remediate motor deficits in chronic stroke patients",
abstract = "Background. Conventional methods of rehabilitation in patients with chronic, severe motor impairments after stroke usually do not lessen paresis. Objective. A novel therapeutic approach (assisted movement with enhanced sensation [AMES]) was employed in a medical device phase I clinical trial to reduce paresis and spasticity and, thereby, to improve motor function. Methods. Twenty subjects more than 1 year poststroke with severe motor disability of the upper or lower extremity were studied. A robotic device cycled the ankle or the wrist and fingers at 5°/s through ±17.5° in flexion and extension while the subject assisted this motion. Feedback of the subject's active torque was displayed on a monitor. Simultaneously, 2 vibrators applied a 60 pps stimulus to the tendons of the lengthening muscles, alternating from flexors to extensors as the joint rotation reversed from extension to flexion, respectively. Subjects treated themselves at home for 30 min/day for 6 months. Every other day prior to treatment, the therapy device performed automated tests of strength and joint positioning. Functional testing was performed prior to enrollment, immediately after completing the protocol, and 6 months later. Functional tests included gait and weight distribution (lower extremity subjects only) and the Stroke Impact Scale. Results. Most subjects improved on most tests, and gains were sustained for 6 months in most subjects. No safety problems arose. Conclusion. The AMES strategy appears safe and possibly effective in patients with severe chronic impairments. The mechanism underlying these gains is likely to be multifactorial.",
keywords = "Chronic, Movement, Rehabilitation, Stroke, Vibration",
author = "Paul Cordo and Helmi Lutsep and Linda Cordo and Wright, {W. Geoffrey} and Timothy Cacciatore and Rachel Skoss",
year = "2009",
month = "1",
doi = "10.1177/1545968308317437",
language = "English (US)",
volume = "23",
pages = "67--77",
journal = "Neurorehabilitation and Neural Repair",
issn = "1545-9683",
publisher = "SAGE Publications Inc.",
number = "1",

}

TY - JOUR

T1 - Assisted movement with enhanced sensation (AMES)

T2 - Coupling motor and sensory to remediate motor deficits in chronic stroke patients

AU - Cordo, Paul

AU - Lutsep, Helmi

AU - Cordo, Linda

AU - Wright, W. Geoffrey

AU - Cacciatore, Timothy

AU - Skoss, Rachel

PY - 2009/1

Y1 - 2009/1

N2 - Background. Conventional methods of rehabilitation in patients with chronic, severe motor impairments after stroke usually do not lessen paresis. Objective. A novel therapeutic approach (assisted movement with enhanced sensation [AMES]) was employed in a medical device phase I clinical trial to reduce paresis and spasticity and, thereby, to improve motor function. Methods. Twenty subjects more than 1 year poststroke with severe motor disability of the upper or lower extremity were studied. A robotic device cycled the ankle or the wrist and fingers at 5°/s through ±17.5° in flexion and extension while the subject assisted this motion. Feedback of the subject's active torque was displayed on a monitor. Simultaneously, 2 vibrators applied a 60 pps stimulus to the tendons of the lengthening muscles, alternating from flexors to extensors as the joint rotation reversed from extension to flexion, respectively. Subjects treated themselves at home for 30 min/day for 6 months. Every other day prior to treatment, the therapy device performed automated tests of strength and joint positioning. Functional testing was performed prior to enrollment, immediately after completing the protocol, and 6 months later. Functional tests included gait and weight distribution (lower extremity subjects only) and the Stroke Impact Scale. Results. Most subjects improved on most tests, and gains were sustained for 6 months in most subjects. No safety problems arose. Conclusion. The AMES strategy appears safe and possibly effective in patients with severe chronic impairments. The mechanism underlying these gains is likely to be multifactorial.

AB - Background. Conventional methods of rehabilitation in patients with chronic, severe motor impairments after stroke usually do not lessen paresis. Objective. A novel therapeutic approach (assisted movement with enhanced sensation [AMES]) was employed in a medical device phase I clinical trial to reduce paresis and spasticity and, thereby, to improve motor function. Methods. Twenty subjects more than 1 year poststroke with severe motor disability of the upper or lower extremity were studied. A robotic device cycled the ankle or the wrist and fingers at 5°/s through ±17.5° in flexion and extension while the subject assisted this motion. Feedback of the subject's active torque was displayed on a monitor. Simultaneously, 2 vibrators applied a 60 pps stimulus to the tendons of the lengthening muscles, alternating from flexors to extensors as the joint rotation reversed from extension to flexion, respectively. Subjects treated themselves at home for 30 min/day for 6 months. Every other day prior to treatment, the therapy device performed automated tests of strength and joint positioning. Functional testing was performed prior to enrollment, immediately after completing the protocol, and 6 months later. Functional tests included gait and weight distribution (lower extremity subjects only) and the Stroke Impact Scale. Results. Most subjects improved on most tests, and gains were sustained for 6 months in most subjects. No safety problems arose. Conclusion. The AMES strategy appears safe and possibly effective in patients with severe chronic impairments. The mechanism underlying these gains is likely to be multifactorial.

KW - Chronic

KW - Movement

KW - Rehabilitation

KW - Stroke

KW - Vibration

UR - http://www.scopus.com/inward/record.url?scp=58149163310&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149163310&partnerID=8YFLogxK

U2 - 10.1177/1545968308317437

DO - 10.1177/1545968308317437

M3 - Article

C2 - 18645190

AN - SCOPUS:58149163310

VL - 23

SP - 67

EP - 77

JO - Neurorehabilitation and Neural Repair

JF - Neurorehabilitation and Neural Repair

SN - 1545-9683

IS - 1

ER -